Skip to main content
OpenTrials
Completed

NCT Number: NCT01008059

Alfentanil: Simultaneous Testing Pilot

To evaluate two paradigms for simultaneous assessment of hepatic and intestinal CYP3A activity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Washington University/Barnes Jewish Hospital

St Louis, Missouri, 63110, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or non-pregnant female, 18-40 yr. old
  • Good general health with no remarkable medical conditions such as liver, kidney, heart, or lung failure
  • BMI between 20-33
  • Provide informed consent

Exclusion criteria

  • Known history of liver or kidney disease
  • Use of prescription or non prescription medications, herbals or foods known to be metabolized by or affect CYP3A (including oral birth control medications)
  • Females who are pregnant or nursing
  • Known history of drug or alcohol addiction (prior or present addiction or treatment for addiction)
  • Direct physical access to and routine handling of addicting drugs in the regular course of duty (this is a routine exclusion from studies of drugs with addiction potential).
  • History of bradycardia
  • Respiratory rate <10
  • History of significant pulmonary disease
  • History of pre-existing medical condition predisposing to respiratory depression
  • Systolic blood pressure <100 mgHg and diastolic blood pressure <70mmHg

Treatment and study plan

alfentanil

Drug

No drug treatment before alfentanil

Primary outcomes

  1. Area Under the Curve of Alfentanil Concentration vs. Time Extrapolated to Infinity

    Time frame: 9 hours

    AUC(0-inf)

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • National Institute of General Medical Sciences (NIGMS)

Registry information

Official study title

Novel Noninvasive Assessment of Cytochrome P4450 Activity: Simultaneous Testing Pilot

Important dates

Study start
2009
Primary completion
2016
Study completion
2016
First posted
Nov 5, 2009
Registry last updated
May 17, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.